About Alafair Biosciences
Alafair Biosciences is a company based in Austin (United States) founded in 2011. It operates as a Direct-to-Consumer (D2C). Alafair Biosciences has raised $13.74 million across 10 funding rounds from investors including HHS, The University of Texas System and Austin Technology Incubator. Alafair Biosciences offers products and services including VersaWrap Hydrogel Sheet and VersaWrap Application Kit. Alafair Biosciences operates in a competitive market with competitors including Imbed Biosciences, MiMedx Group, Ossio, Cresilon and EpiBone, among others.
- Headquarter Austin, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alafair Biosciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.74 M (USD)
in 10 rounds
-
Latest Funding Round
$7.2 M (USD), Series B
Apr 18, 2019
-
Investors
HHS
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alafair Biosciences
Alafair Biosciences offers a comprehensive portfolio of products and services, including VersaWrap Hydrogel Sheet and VersaWrap Application Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A bioresorbable hydrogel for soft-tissue protection is provided.
A kit for applying VersaWrap hydrogel is included.
Unlock access to complete
Funding Insights of Alafair Biosciences
Alafair Biosciences has successfully raised a total of $13.74M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $7.2 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $7.2M
-
First Round
First Round
(05 Jan 2012)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Series B - Alafair Biosciences | Valuation |
investors |
|
| Oct, 2018 | Amount | Series A - Alafair Biosciences | Valuation |
investors |
|
| Jul, 2017 | Amount | Debt – Conventional - Alafair Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alafair Biosciences
Alafair Biosciences has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, The University of Texas System and Austin Technology Incubator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep tech commercialization is facilitated by Austin Technology Incubator.
|
Founded Year | Domain | Location | |
|
Early-stage venture funding is provided by ATP Fund for scientific innovation.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alafair Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alafair Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alafair Biosciences Comparisons
Competitors of Alafair Biosciences
Alafair Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, MiMedx Group, Ossio, Cresilon and EpiBone, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanotech-based wound care products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic products for wound care
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
|
| domain | founded_year | HQ Location |
Synthetic calcium composites are developed for bone repair and regeneration.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alafair Biosciences
Frequently Asked Questions about Alafair Biosciences
When was Alafair Biosciences founded?
Alafair Biosciences was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Alafair Biosciences located?
Alafair Biosciences is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Is Alafair Biosciences a funded company?
Alafair Biosciences is a funded company, having raised a total of $13.74M across 10 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $965K, raised on Jan 05, 2012.
What does Alafair Biosciences do?
Alafair Biosciences is focused on developing biopolymer technologies for soft-tissue protection. Solutions are provided to reduce scarring, enhance mobility, and accelerate patient recovery in surgical procedures. Applications are targeted across lower extremity, upper extremity, spine, and plastic and reconstructive surgeries. The flagship product, VersaWrap Hydrogel Sheet, is designed to prevent tissue tethering and support natural movement. The company operates within the healthcare sector, emphasizing medical devices for surgical applications.
Who are the top competitors of Alafair Biosciences?
Alafair Biosciences's top competitors include Imbed Biosciences, EpiBone and Theradaptive.
What products or services does Alafair Biosciences offer?
Alafair Biosciences offers VersaWrap Hydrogel Sheet and VersaWrap Application Kit.
Who are Alafair Biosciences's investors?
Alafair Biosciences has 5 investors. Key investors include HHS, The University of Texas System, Austin Technology Incubator, ATP Fund, and Texas Emerging Technology Fund.